Lipocine, Inc. (LPCN)
2.315
+0.06
(+2.89%)
USD |
NASDAQ |
Sep 10, 16:00
2.315
0.00 (0.00%)
After-Hours: 16:25
Lipocine Total Assets (Quarterly) : 23.84M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.84M |
| March 31, 2026 | 25.36M |
| December 31, 2025 | 17.01M |
| September 30, 2025 | 16.07M |
| June 30, 2025 | 18.58M |
| March 31, 2025 | 20.50M |
| December 31, 2024 | 22.51M |
| September 30, 2024 | 20.70M |
| June 30, 2024 | 23.03M |
| March 31, 2024 | 25.45M |
| December 31, 2023 | 23.00M |
| September 30, 2023 | 24.75M |
| June 30, 2023 | 30.48M |
| March 31, 2023 | 34.02M |
| December 31, 2022 | 37.54M |
| September 30, 2022 | 39.42M |
| June 30, 2022 | 42.19M |
| March 31, 2022 | 47.60M |
| December 31, 2021 | 52.48M |
| September 30, 2021 | 40.39M |
| June 30, 2021 | 47.18M |
| March 31, 2021 | 50.58M |
| December 31, 2020 | 25.35M |
| September 30, 2020 | 24.75M |
| June 30, 2020 | 23.49M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.99M |
| December 31, 2019 | 19.66M |
| September 30, 2019 | 17.34M |
| June 30, 2019 | 19.68M |
| March 31, 2019 | 22.99M |
| December 31, 2018 | 20.85M |
| September 30, 2018 | 22.69M |
| June 30, 2018 | 25.30M |
| March 31, 2018 | 31.68M |
| December 31, 2017 | 25.33M |
| September 30, 2017 | 26.26M |
| June 30, 2017 | 28.05M |
| March 31, 2017 | 27.22M |
| December 31, 2016 | 27.34M |
| September 30, 2016 | 29.55M |
| June 30, 2016 | 33.35M |
| March 31, 2016 | 38.77M |
| December 31, 2015 | 45.38M |
| September 30, 2015 | 48.43M |
| June 30, 2015 | 53.80M |
| March 31, 2015 | 25.06M |
| December 31, 2014 | 27.99M |
| September 30, 2014 | 32.02M |
| June 30, 2014 | 35.49M |
| March 31, 2014 | 42.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.068M |
| Shareholders Equity (Quarterly) | 21.77M |
| Current Ratio | 11.48 |